Andrea Amalfitano - Search Results

Year	Number of Results
2002	5
2003	4
2004	3
2005	6
2006	6
2007	5
2008	5
2009	8
2010	10
2011	11
2012	6
2013	7
2014	3
2015	3
2016	2
2017	3
2018	5
2019	6
2020	1
2021	3
2022	3
2024	0

1

The role of ERAP1 in autoinflammation and autoimmunity.

Pepelyayeva Y, Amalfitano A. Pepelyayeva Y, et al. Among authors: amalfitano a. Hum Immunol. 2019 May;80(5):302-309. doi: 10.1016/j.humimm.2019.02.013. Epub 2019 Feb 25. Hum Immunol. 2019. PMID: 30817945 Review.

2

Current and Future Treatments for Lysosomal Storage Disorders.

Rastall DPW, Amalfitano A. Rastall DPW, et al. Among authors: amalfitano a. Curr Treat Options Neurol. 2017 Nov 4;19(12):45. doi: 10.1007/s11940-017-0481-2. Curr Treat Options Neurol. 2017. PMID: 29101575 Review.

3

SLAM Family Receptor Signaling in Viral Infections: HIV and Beyond.

O'Connell P, Amalfitano A, Aldhamen YA. O'Connell P, et al. Among authors: amalfitano a. Vaccines (Basel). 2019 Nov 16;7(4):184. doi: 10.3390/vaccines7040184. Vaccines (Basel). 2019. PMID: 31744090 Free PMC article. Review.

4

SLAMF7 modulates B cells and adaptive immunity to regulate susceptibility to CNS autoimmunity.

O'Connell P, Blake MK, Godbehere S, Amalfitano A, Aldhamen YA. O'Connell P, et al. Among authors: amalfitano a. J Neuroinflammation. 2022 Oct 3;19(1):241. doi: 10.1186/s12974-022-02594-9. J Neuroinflammation. 2022. PMID: 36199066 Free PMC article.

5

Malaria vaccines: focus on adenovirus based vectors.

Schuldt NJ, Amalfitano A. Schuldt NJ, et al. Among authors: amalfitano a. Vaccine. 2012 Jul 27;30(35):5191-8. doi: 10.1016/j.vaccine.2012.05.048. Epub 2012 Jun 7. Vaccine. 2012. PMID: 22683663 Review.

6

Recent advances in gene therapy for lysosomal storage disorders.

Rastall DP, Amalfitano A. Rastall DP, et al. Among authors: amalfitano a. Appl Clin Genet. 2015 Jun 24;8:157-69. doi: 10.2147/TACG.S57682. eCollection 2015. Appl Clin Genet. 2015. PMID: 26170711 Free PMC article. Review.

7

Adenovirus vectors for renal-targeted gene delivery.

Appledorn DM, Seregin S, Amalfitano A. Appledorn DM, et al. Among authors: amalfitano a. Contrib Nephrol. 2008;159:47-62. doi: 10.1159/000125581. Contrib Nephrol. 2008. PMID: 18391584 Review.

8

Gene therapy for lysosomal storage diseases: progress, challenges and future prospects.

Seregin SS, Amalfitano A. Seregin SS, et al. Among authors: amalfitano a. Curr Pharm Des. 2011;17(24):2558-74. doi: 10.2174/138161211797247578. Curr Pharm Des. 2011. PMID: 21774776 Review.

9

Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors.

Seregin SS, Amalfitano A. Seregin SS, et al. Among authors: amalfitano a. Expert Opin Biol Ther. 2009 Dec;9(12):1521-31. doi: 10.1517/14712590903307388. Expert Opin Biol Ther. 2009. PMID: 19780714 Review.

10

Toll-like receptors impact on safety and efficacy of gene transfer vectors.

Hensley SE, Amalfitano A. Hensley SE, et al. Among authors: amalfitano a. Mol Ther. 2007 Aug;15(8):1417-22. doi: 10.1038/sj.mt.6300217. Epub 2007 Jun 5. Mol Ther. 2007. PMID: 17551505 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

91 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year